181 related articles for article (PubMed ID: 19267250)
1. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.
Pierce BL; Biggs ML; DeCambre M; Reiner AP; Li C; Fitzpatrick A; Carlson CS; Stanford JL; Austin MA
Cancer Causes Control; 2009 Sep; 20(7):1193-203. PubMed ID: 19267250
[TBL] [Abstract][Full Text] [Related]
2. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
[TBL] [Abstract][Full Text] [Related]
3. IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study.
Walston JD; Fallin MD; Cushman M; Lange L; Psaty B; Jenny N; Browner W; Tracy R; Durda P; Reiner A
Hum Genet; 2007 Dec; 122(5):485-94. PubMed ID: 17851695
[TBL] [Abstract][Full Text] [Related]
4. Circulating IL-10 is associated with reduced risk of prostate cancer in a prospective cohort of elderly men: the MrOS Study.
Thomas CE; Bauer DC; Yuan JM; Cauley JA
Cancer Causes Control; 2023 Jan; 34(1):59-68. PubMed ID: 36239865
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study.
Demb J; Wei EK; Izano M; Kritchevsky S; Swede H; Newman AB; Shlipak M; Akinyemiju T; Gregorich S; Braithwaite D
J Geriatr Oncol; 2019 Mar; 10(2):265-271. PubMed ID: 30078713
[TBL] [Abstract][Full Text] [Related]
6. Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population.
Ognjanovic S; Yamamoto J; Saltzman B; Franke A; Ognjanovic M; Yokochi L; Vogt T; Decker R; Le Marchand L
Cancer Causes Control; 2010 Jul; 21(7):1131-8. PubMed ID: 20333461
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study.
Hussein AA; Gottdiener JS; Bartz TM; Sotoodehnia N; DeFilippi C; See V; Deo R; Siscovick D; Stein PK; Lloyd-Jones D
Heart Rhythm; 2013 Oct; 10(10):1425-32. PubMed ID: 23906927
[TBL] [Abstract][Full Text] [Related]
8. The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6-174G > C gene polymorphism.
Wypasek E; Undas A; Sniezek-Maciejewska M; Kapelak B; Plicner D; Stepien E; Sadowski J
Ann Clin Biochem; 2010 Jul; 47(Pt 4):343-9. PubMed ID: 20592333
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.
Lange LA; Carlson CS; Hindorff LA; Lange EM; Walston J; Durda JP; Cushman M; Bis JC; Zeng D; Lin D; Kuller LH; Nickerson DA; Psaty BM; Tracy RP; Reiner AP
JAMA; 2006 Dec; 296(22):2703-11. PubMed ID: 17164456
[TBL] [Abstract][Full Text] [Related]
10. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
[TBL] [Abstract][Full Text] [Related]
11. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.
Stark JR; Li H; Kraft P; Kurth T; Giovannucci EL; Stampfer MJ; Ma J; Mucci LA
Int J Cancer; 2009 Jun; 124(11):2683-9. PubMed ID: 19189403
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in RNASEL associated with prostate cancer risk and progression.
Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
[TBL] [Abstract][Full Text] [Related]
13. IL-6 Genomic Variants and Risk of Prostate Cancer.
Taheri M; Noroozi R; Rakhshan A; Ghanbari M; Omrani MD; Ghafouri-Fard S
Urol J; 2019 Oct; 16(5):463-468. PubMed ID: 30345492
[TBL] [Abstract][Full Text] [Related]
14. Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration.
Ambreen F; Ismail M; Qureshi IZ
Mol Vis; 2015; 21():985-99. PubMed ID: 26330749
[TBL] [Abstract][Full Text] [Related]
15. Effects of cholesterol, C-reactive protein, and interleukin-6 on prostate cancer risk in a population of African ancestry.
Tulloch-Reid MK; McFarlane-Anderson N; Bennett FI; Aiken WD; Jackson MD
Cancer Causes Control; 2017 Nov; 28(11):1313-1321. PubMed ID: 28864928
[TBL] [Abstract][Full Text] [Related]
16. Variants in C-reactive protein and IL-6 genes and susceptibility to obstructive sleep apnea in children: a candidate-gene association study in European American and Southeast European populations.
Kaditis AG; Gozal D; Khalyfa A; Kheirandish-Gozal L; Capdevila OS; Gourgoulianis K; Alexopoulos EI; Chaidas K; Bhattacharjee R; Kim J; Rodopoulou P; Zintzaras E
Sleep Med; 2014 Feb; 15(2):228-35. PubMed ID: 24380782
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers and cognition in well-functioning African-American and white elders.
Yaffe K; Lindquist K; Penninx BW; Simonsick EM; Pahor M; Kritchevsky S; Launer L; Kuller L; Rubin S; Harris T
Neurology; 2003 Jul; 61(1):76-80. PubMed ID: 12847160
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation across C-reactive protein and risk of prostate cancer.
Markt SC; Rider JR; Penney KL; Schumacher FR; Epstein MM; Fall K; Sesso HD; Stampfer MJ; Mucci LA
Prostate; 2014 Jul; 74(10):1034-42. PubMed ID: 24844401
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers and incident heart failure in older men: the role of NT-proBNP.
McKechnie DG; Papacosta AO; Lennon LT; Welsh P; Whincup PH; Wannamethee SG
Biomark Med; 2021 Apr; 15(6):413-425. PubMed ID: 33709785
[TBL] [Abstract][Full Text] [Related]
20. Levels of acute inflammatory biomarkers in advanced prostate cancer patients with α2-macroglobulin deficiency.
Kanoh Y; Ohtani H; Egawa S; Baba S; Akahoshi T
Int J Oncol; 2011 Dec; 39(6):1553-8. PubMed ID: 21894431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
